Table 1.

Characteristics of the study subjects

Study subjects	Healthy subjects (n = 15)	Treatment-naive patients (n = 31)	Patients receiving antiviral treatment(n = 16)	Patients achieving SVR (n = 10)
Age (years), mean (range)	32·1 (22–43)	34·3 (17–46)	37·8 (21–50)	39·6 (27–52)
Gender (male/female)	10/5	22/9	10/6	7/3
Genotype (G1/G2)	N/A	15/16	9/7	4/6
HCV viral load (105 IU/μl), mean (range)	N/A	66·86 (1·30–371)	N/A	N/A

HCV, hepatitis C virus; N/A, not applicable; SVR, sustained virological response.